These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 28189593)

  • 1. External Validation of a Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer.
    Nieder C; Tollåli T; Haukland E; Reigstad A; Flatøy LR; Dalhaug A
    Clin Lung Cancer; 2017 Jul; 18(4):e297-e301. PubMed ID: 28189593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Survival Score for Patients Receiving Palliative Irradiation for Locally Advanced Lung Cancer.
    Rades D; Käsmann L; Schild SE; Janssen S
    Clin Lung Cancer; 2016 Nov; 17(6):558-562. PubMed ID: 27341791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative Lung Radiotherapy: Higher Dose Leads to Improved Survival?
    Lewis TS; Kennedy JA; Price GJ; Mee T; Woolf DK; Bayman NA; Chan C; Coote JH; Faivre-Finn C; Harris MA; Hudson AM; Pemberton LS; Salem A; Sheikh HY; Mistry HB; Cobben DCP
    Clin Oncol (R Coll Radiol); 2020 Oct; 32(10):674-684. PubMed ID: 32600918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated Onco-Palliative Care Associated With Prolonged Survival Compared to Standard Care for Patients With Advanced Lung Cancer: A Retrospective Review.
    King JD; Eickhoff J; Traynor A; Campbell TC
    J Pain Symptom Manage; 2016 Jun; 51(6):1027-32. PubMed ID: 26948411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Four-Tiered Prognostic Score for Patients Receiving Palliative Thoracic Radiotherapy for Lung Cancer.
    Nieder C; Tollåli T; Haukland E; Reigstad A; Randi Flatøy L; Dalhaug A
    Cancer Invest; 2018 Jan; 36(1):59-65. PubMed ID: 29319371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fractionated palliative thoracic radiotherapy in non-small cell lung cancer - futile or worth-while?
    Støchkel Frank M; Schou Nørøxe D; Nygård L; Fredberg Persson G
    BMC Palliat Care; 2018 Jan; 17(1):15. PubMed ID: 29304789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Palliative care units in lung cancer in the real-world setting: a single institution's experience and its implications.
    Masel EK; Schur S; Nemecek R; Mayrhofer M; Huber P; Adamidis F; Maehr B; Unseld M; Watzke HH; Pirker R
    Ann Palliat Med; 2017 Jan; 6(1):6-13. PubMed ID: 27701880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Palliative thoracic radiotherapy in locally advanced non-small cell lung cancer: can quality-of-life assessments help in selection of patients for short- or long-course radiotherapy?
    Sundstrøm S; Bremnes RM; Brunsvig P; Aasebø U; Kaasa S;
    J Thorac Oncol; 2006 Oct; 1(8):816-24. PubMed ID: 17409965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.
    Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL
    Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation.
    Rutter CE; Park HS; Corso CD; Yeboa DN; Mancini BR; Lester-Coll NH; Kim AW; Decker RH
    Lung Cancer; 2015 Nov; 90(2):243-8. PubMed ID: 26277031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palliative systemic therapy for advanced non-small cell lung cancer: Investigating disparities between patients who are treated versus those who are not.
    Brule SY; Al-Baimani K; Jonker H; Zhang T; Nicholas G; Goss G; Laurie SA; Wheatley-Price P
    Lung Cancer; 2016 Jul; 97():15-21. PubMed ID: 27237022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How Do Elderly Poor Prognosis Patients Tolerate Palliative Concurrent Chemoradiotherapy for Locally Advanced Non-Small-Cell Lung Cancer Stage III? A Subset Analysis From a Clinical Phase III Trial.
    Strøm HH; Bremnes RM; Sundstrøm SH; Helbekkmo N; Aasebø U
    Clin Lung Cancer; 2015 May; 16(3):183-92. PubMed ID: 25481662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The survival outcomes and prognosis of stage IV non-small-cell lung cancer treated with thoracic three-dimensional radiotherapy combined with chemotherapy.
    Su S; Hu Y; Ouyang W; Ma Z; Lu B; Li Q; Li H; Wang Z; Wang Y
    Radiat Oncol; 2014 Dec; 9():290. PubMed ID: 25518882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
    Koch A; Fohlin H; Sörenson S
    J Thorac Oncol; 2009 Mar; 4(3):326-32. PubMed ID: 19155996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
    Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
    J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
    Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
    J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment modality selection and prognosis of early stage small cell lung cancer: retrospective analysis from a single cancer institute.
    Zhu H; Zhou Z; Xue Q; Zhang X; He J; Wang L
    Eur J Cancer Care (Engl); 2013 Nov; 22(6):789-96. PubMed ID: 23763282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis.
    Rodrigues G; Oberije C; Senan S; Tsujino K; Wiersma T; Moreno-Jimenez M; Kim TH; Marks LB; Rengan R; De Petris L; Ramella S; DeRuyck K; De Dios NR; Warner A; Bradley JD; Palma DA
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):133-9. PubMed ID: 25835622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
    Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
    Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors associated with interventional bronchoscopy in lung cancer.
    Guibert N; Mazieres J; Lepage B; Plat G; Didier A; Hermant C
    Ann Thorac Surg; 2014 Jan; 97(1):253-9. PubMed ID: 24094520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.